0002156954-26-000001.txt : 20260923 0002156954-26-000001.hdr.sgml : 20260923 20260923161117 ACCESSION NUMBER: 0002156954-26-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260923 DATE AS OF CHANGE: 20260923 EFFECTIVENESS DATE: 20260923 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Uvantis Therapeutics, Inc. CENTRAL INDEX KEY: 0002156954 ORGANIZATION NAME: EIN: 393374578 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-598636 FILM NUMBER: 261401130 BUSINESS ADDRESS: STREET 1: 10980 GRANTCHESTER WAY CITY: COLUMBIA STATE: MD ZIP: 21044 BUSINESS PHONE: 6174176695 MAIL ADDRESS: STREET 1: 10980 GRANTCHESTER WAY CITY: COLUMBIA STATE: MD ZIP: 21044 D 1 primary_doc.xml X0708 D LIVE 0002156954 Uvantis Therapeutics, Inc. 10980 GRANTCHESTER WAY COLUMBIA MD MARYLAND 21044 6174176695 DELAWARE None None Corporation true 2025 William Sheahan 10980 GRANTCHESTER WAY Columbia MD MARYLAND 21044 Director Jonathan Young 10980 GRANTCHESTER WAY Columbia MD MARYLAND 21044 Director Edward Woo 10980 GRANTCHESTER WAY Columbia MD MARYLAND 21044 Director Paul Giannasca 10980 GRANTCHESTER WAY Columbia MD MARYLAND 21044 Executive Officer Jeffrey Collins 10980 GRANTCHESTER WAY Columbia MD MARYLAND 21044 Executive Officer Biotechnology Decline to Disclose 06b false 2026-09-10 false true true false 0 5000000 100000 4900000 false 1 0 0 0 false Uvantis Therapeutics, Inc. /s/ Omkar Mahajan Omkar Mahajan Attorney for Issuer 2026-09-23